Viewing Study NCT05951959


Ignite Creation Date: 2025-12-24 @ 2:47 PM
Ignite Modification Date: 2025-12-26 @ 2:57 AM
Study NCT ID: NCT05951959
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-21
First Post: 2023-06-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Acalabrutinib Plus Venetoclax and Rituximab in Participants With Treatment Naïve Mantle Cell Lymphoma
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module